Federation Des Caisses Desjardins Du Quebec Journey Medical Corp Transaction History
Federation Des Caisses Desjardins Du Quebec
- $23.7 Billion
- Q3 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Journey Medical Corp stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 300 shares of DERM stock, worth $2,382. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 300
-0.0%
Holding current value
$2,382
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding DERM
# of Institutions
69Shares Held
8.96MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$14.7 Million0.6% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.31MShares$10.4 Million0.05% of portfolio
-
Opaleye Management Inc. Boston, MA971KShares$7.71 Million1.15% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$6.87 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA615KShares$4.88 Million0.0% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $92.1M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...